These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 17966954)
1. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease. Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954 [TBL] [Abstract][Full Text] [Related]
2. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy. Todorović Z; Dzoljić E; Novaković I; Mirković D; Stojanović R; Nesić Z; Krajinović M; Prostran M; Kostić V J Neurol Sci; 2006 Oct; 248(1-2):56-61. PubMed ID: 16774768 [TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease. Religa D; Czyzewski K; Styczynska M; Peplonska B; Lokk J; Chodakowska-Zebrowska M; Stepien K; Winblad B; Barcikowska M Neurosci Lett; 2006 Aug; 404(1-2):56-60. PubMed ID: 16787708 [TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients. Yuan RY; Sheu JJ; Yu JM; Hu CJ; Tseng IJ; Ho CS; Yeh CY; Hung YL; Chiang TR J Neurol Sci; 2009 Dec; 287(1-2):64-8. PubMed ID: 19786283 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621 [TBL] [Abstract][Full Text] [Related]
6. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062 [TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase C677T genotype and PD. de Lau LM; Koudstaal PJ; van Meurs JB; Uitterlinden AG; Hofman A; Breteler MM Ann Neurol; 2005 Jun; 57(6):927-30. PubMed ID: 15929053 [TBL] [Abstract][Full Text] [Related]
8. Family history, plasma homocysteine, and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes. Mager A; Koren-Morag N; Shohat M; Harell D; Battler A Am J Cardiol; 2005 Jun; 95(12):1420-4. PubMed ID: 15950563 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure. Lutz UC; Batra A; Kolb W; Machicao F; Maurer S; Köhnke MD Alcohol Clin Exp Res; 2006 Dec; 30(12):1966-71. PubMed ID: 17117960 [TBL] [Abstract][Full Text] [Related]
10. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia. Al-Ali AK; Al-Muhana FA; Larbi EB; Abdulmohsen MF; Al-Sultan AI; Al-Maden MS; Al-Ateeq SA Saudi Med J; 2005 Dec; 26(12):1886-8. PubMed ID: 16380767 [TBL] [Abstract][Full Text] [Related]
11. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. Wu YL; Ding XX; Sun YH; Yang HY; Sun L J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Parsian A; Racette B; Goldsmith LJ; Perlmutter JS Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377 [TBL] [Abstract][Full Text] [Related]
15. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women. Lin JJ; Yueh KC; Chang CY; Chen CH; Lin SZ Parkinsonism Relat Disord; 2004 Dec; 10(8):469-73. PubMed ID: 15542006 [TBL] [Abstract][Full Text] [Related]
16. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. Joshi G; Pradhan S; Mittal B J Neurol Sci; 2009 Feb; 277(1-2):133-7. PubMed ID: 19081115 [TBL] [Abstract][Full Text] [Related]
17. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility]. Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629 [TBL] [Abstract][Full Text] [Related]
18. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234 [TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy. Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145 [TBL] [Abstract][Full Text] [Related]
20. The methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm. Jones GT; Harris EL; Phillips LV; van Rij AM Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):137-42. PubMed ID: 15996600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]